Recently, the BIONNOVA2024 Beijing Innovation Forum was successfully held in Beijing. This grand event brought together numerous elite professionals, academic authorities, and entrepreneurs in the pharmaceutical industry, showcasing the latest research achievements and market dynamics in the field of medicine. It also provided a platform for in-depth communication and collaboration among various parties. As a representative of a technology-driven Contract Development and Manufacturing Organization (CDMO) in the pharmaceutical industry, Laviana Pharma appeared at the conference with its research and business teams.
The forum lasted for two days, inviting over a hundred authoritative leaders and thousands of industry experts to conduct in-depth analysis on various sub-fields such as antibody drugs, ADC drugs, immunocell therapy, stem cell therapy, gene therapy, nucleic acid drugs, small molecule innovative drugs, and targeted protein degradation drugs. Scholars at the meeting engaged in lively discussions on core topics of drug development such as early discovery, preclinical research, clinical trials, production processes, and BD commercialization, exploring new opportunities in the industry transformation together.
Since its establishment in 2003. Laviana Pharma has always adhered to the corporate culture of "Respect People , Sustainable Science , Team Work , Market Oriented , Accelerate Development ", with a mission of "Changing the World with the Art of Chemistry ", continuously improving and optimizing its technology. After twenty years of industry experience, the company has developed strong market competitiveness in the field of chemical design and production services, earning praise and trust from customers worldwide.
At this forum, Laviana Pharma not only showcased its latest research and development achievements in the pharmaceutical field, but also actively discussed collaboration opportunities with industry colleagues to jointly promote innovation and development in the industry.
In the future, we will continue to increase investment in research and development and production, empower through innovative technologies and strategic location layout, and strive to become a flagship enterprise in the professional CDMO field. We aim to provide comprehensive one-stop services for more innovative pharmaceutical companies at home and abroad, accelerating the pace of global pharmaceutical innovation.